ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makhoul, R. G.
Right arrow Articles by Lowe, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makhoul, R. G.
Right arrow Articles by Lowe, J. E.

The Annals of Thoracic Surgery, Vol 43, 617-621, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery

RG Makhoul, RL McCann, EH Austin, CS Greenberg and JE Lowe

Heparin-associated thrombocytopenia and thrombosis (HATT) is a serious complication of heparin therapy that results in intravascular platelet aggregation with arterial or venous thrombosis. Platelet aggregation to heparin in vitro is used to confirm the diagnosis. Cessation of heparin therapy with avoidance of reexposure to heparin is an important principle in the management of HATT. However, certain patients with HATT may require reexposure to heparin for emergency cardiac operations requiring cardiopulmonary bypass while still demonstrating positive in vitro platelet aggregation with heparin. The present report describes the management of 2 such patients. In each patient aspirin was shown to inhibit platelet aggregation to heparin in vitro; therefore, aspirin and dipyridamole were administered to each patient before heparin reexposure and continued throughout the perioperative period. Cardiopulmonary bypass with full heparinization was achieved without thrombotic or hemorrhagic complications in both patients. Despite the presence of a heparin-dependent platelet-aggregating factor in the plasma of these 2 patients, inhibition of platelet aggregation with aspirin and dipyridamole allowed uneventful reexposure to heparin.


This article has been cited by other articles:


Home page
ChestHome page
N. Lubenow, R. Kempf, A. Eichner, P. Eichler, L. E. Carlsson, and A. Greinacher
Heparin-Induced Thrombocytopenia* : Temporal Pattern of Thrombocytopenia in Relation to Initial Use or Reexposure to Heparin
Chest, July 1, 2002; 122(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Follis and C. A. Schmidt
Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis
Ann. Thorac. Surg., December 1, 2000; 70(6): 2173 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
M. P Reilly, R. Weiss, A. Askenase, C. Tuite, M. Soulen, and E. R Mohler III
Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia
Vascular Medicine, November 1, 2000; 5(4): 239 - 242.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
D. E. Wallis, B. E. Lewis, H. Messmore, and W. H. Wehrmacher
State-of-the-Art Review : Heparin-induced Thrombocytopenia and Thrombosis Syndrome
Clinical and Applied Thrombosis/Hemostasis, July 1, 1998; 4(3): 160 - 163.
[PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
D. Cummins and E. Hill
Heparin-Induced Thrombocytopenia
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 349 - 365.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Kalangos, J. Y. M. Relland, A. Altes, R. Martino, M. Gari, M. L. Camara, R. Garin, J.-I. Casas, and J. Fontcuberta
Therapeutic Implications for Heparin-Induced Thrombocytopenia and Thrombosis
Ann. Thorac. Surg., October 1, 1995; 60(4): 1159 - 1160.
[Full Text]


Home page
ANGIOLOGYHome page
S. Kleinschmidt and U.T. Seyfert
Heparin-Associated Thrombocytopenia (HAT)--Still a Diagnostic and Therapeutical Problem in Clinical Practice
Angiology, January 1, 1995; 46(1): 37 - 44.
[Abstract] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
M. Sobel
Heparin-Induced Thrombocytopenia
Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1992; 5(2): 1 - 27.
[PDF]


Home page
ANGIOLOGYHome page
H. Van Damme, P. Damas, J.L. David, and R. Limet
Heparin-Induced Thrombocytopenia: A Case Report
Angiology, December 1, 1990; 41(12): 1075 - 1081.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
D. J. Cohen, R. Briggs, H. D. Head, and C. W. Acher
Phlegmasia Cerulea Dolens and Its Association with Hypercoagulable States: Case Reports
Angiology, May 1, 1989; 40(5): 498 - 508.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.